Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep520 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Short and long-term glycemic variability associated with severe hypoglycemia and retinopathy in type 1 diabetes mellitus

Sanz Martín Borja , Roman Gimeno Sergio , Miguel Peteiro Miranda Carlos , Jorge Ortez Toro Jose , Agudo Ana , Urdaniz Rosana , Antonio Gimeno Orna José

Introduction: Severe hypoglycemia and retinopathy are two of the main complications of diabetes mellitus (DM). Traditionally, glycosylated hemoglobin (or A1C) has been used as the gold standard measurement of glycemic control; however, there is a significant percentage of complications riskassociated with the evolution of diabetes that is not fully explained by this single marker. Short and long-term glycemic variability has been postulated as one of the main variables that co...

ea0070aep1048 | Hot topics (including COVID-19) | ECE2020

Diabetes and COVID-19

Miguel Peteiro Miranda Carlos , Jorge Ortez Toro Jose , Sanz Martín Borja , Román Gimeno Sergio , Urdaiz Borque Rosana , Tabuenca Ana Agudo , Gimeno Orna Jose Antonio

Background: Although obesity and has been associated with COVID-19 mortality, the absolute and relative risks for Type 2 diabetes (DM2) is unknown. The aim of this study was to analyse metabolic characteristics of patients infected by COVID-19 hospitalised and evaluate whether DM2 have an impact in this group of patients.Methods: We retrospectively analysed data of COVID-19 patients hospitalized to a large academic hospital system in Zaragoza between Mar...

ea0070aep890 | Thyroid | ECE2020

New predictors of response to treatment with intravenous methylprednisolone in thyroid-associated orbitopathy

Roman Gimeno Sergio , Jorge Ortez Toro Jose , Miguel Peteiro Miranda Carlos , Sanz Martín Borja , Urdaniz Rosana , Agudo Ana , Borau Laura , Campos Fernández Julia , Aguillo Gutierrez Esperanza

Introduction: Thyroid-associated ophthalmopathy is the most frequent extrathyroidal manifestation of Graves’ disease. Its treatment is based on the administration of intravenous corticosteroids, and the clinical activity score (CAS), TSH-binding inhibitor immunoglobulin (TBII) and TSH-receptor antibodies (TRAb) have been classically used to measure the response to treatment. However, in recent studies [1] it has been observed that other analytical parameters such as chol...